Érudit | Dépôt de documents >
CIRPÉE - Centre interuniversitaire sur le risque, les politiques économiques et l'emploi >
Cahiers de recherche du CIRPÉE >

Please use this identifier to cite or link to this item:

Title: The Value of Medical and Pharmaceutical Interventions for Reducing Obesity
Authors: Michaud, Pierre-Carl
Lakdawalla, Darius
Zheng, Yuhui
Gailey, Adam H.
Goldman, Dana
Keywords: Obesity
Health Spending
Issue Date: 2011-03
Series/Report no.: Cahiers du CIRPÉE;11-09
Abstract: This paper attempts to quantify the private and public economic value of reducing obesity through pharmaceutical and medical interventions. We find that the economic value of such treatments, in particular bariatric surgery, is large for treated patients, with incremental cost-effectiveness ratios typically under $20,000 per life-year saved. Our approach accounts for competing risks to life expectancy, health care cost savings, and other non-medical fiscal consequences. Most of the therapeutic value is generated by longer healthy life expectancy, with modest contributions from health spending, taxes and other spending. Obesity treatment generates substantial per-period savings in medical costs, but it also raises lifetime medical and annuity costs by extending life. On balance, treatment generates substantial private economic value and lowers the prevalence of obesity, but the aggregate fiscal effects on the public-sector are small.
Appears in Collections:Cahiers de recherche du CIRPÉE

Files in This Item:

CIRPEE11-09.pdf, (Adobe PDF ; 3.26 MB)

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.


About Érudit | Subscriptions | RSS | Terms of Use | Contact us |

Consortium Érudit ©  2016